Prenatal detection of trisomy 9 mosaicism

S. Schwartz, S. Ashai, E. J. Meijboom, M. F. Schwartz, C. C.‐J Sun, M. M. Cohen

Research output: Contribution to journalArticlepeer-review

25 Scopus citations


Chromosomal mosaicism in amniotic fluid cells poses a serious dilemma in prenatal diagnosis since the observation may represent: (1) pseudomosaicism—an inconsequential tissue culture artefact; or (2) true mosaicism—occurring in approximately 0.0 per cent of amniocenteses with a significant impact on pregnancy outcome. Mosaicism for trisomy 9 was observed in an amniotic fluid specimen obtained for advanced maternal age with two cell lines [46,XX (46 per cent)/47,XX, + 9 (54 per cent)] present in each of four culture flasks. Since more than 75 per cent of newborns with trisomy 9 mosaicism have complex cardiac malformations, a fetal echocardiogram was obtained at 20 weeks' gestation and interpreted as normal. A fetal blood sample (22 weeks' gestation) disclosed only a single trisomy 9 cell among the 100 metaphases analysed. However, a second fetal echocardiogram performed at the time of blood sampling suggested a non‐specific cardiac anomaly. Fetal autopsy following elective pregnancy termination revealed several malformations including severe micrognathia, persistence of the left superior vena cava, and skeletal anomalies. Cytogenetic studies of cell cultures derived from several fetal tissues demonstrated trisomy 9 ranging from 12 to 24 per cent.

Original languageEnglish (US)
Pages (from-to)549-554
Number of pages6
JournalPrenatal Diagnosis
Issue number8
StatePublished - Aug 1989
Externally publishedYes


  • Fetal blood sampling
  • Fetal echocardiography
  • Mosaicism
  • Prenatal diagnosis
  • Trisomy 9

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Genetics(clinical)


Dive into the research topics of 'Prenatal detection of trisomy 9 mosaicism'. Together they form a unique fingerprint.

Cite this